The Oral Selective Inhibitor of Nuclear Export ( SINE) Selinexor (KPT-330) Demonstrates Broad and Durable Clinical Activity in Relapsed / Refractory Non Hodgkin's Lymphoma (NHL)

被引：0

作者：

Kuruvilla, John ^{[1
]}

Byrd, John C. ^{[2
]}

Flynn, Joseph M. ^{[3
]}

Garzon, Ramiro ^{[3
]}

Porcu, Pierluigi ^{[2
]}

Wagner-Johnston, Nina ^{[4
]}

Savoie, Mary Lynn ^{[5
]}

Stone, Richard M. ^{[6
]}

Jacobsen, Eric D. ^{[6
]}

Mau-Sorensen, Morten ^{[7
]}

Brown, Peter de Nully ^{[8
]}

Baz, Rachid ^{[9
]}

Shal, Bijal ^{[9
]}

Flinn, Ian ^{[10
]}

Gabrail, Nashat ^{[11
]}

Kukreti, Vishal ^{[12
]}

Tiedemann, Rodger E. ^{[12
]}

Landesman, Yosef ^{[13
]}

Klebanov, Boris ^{[13
]}

Shacham, Eran ^{[13
]}

Saint-Martin, Jean-Richard ^{[13
]}

Marshall, Tracey ^{[13
]}

McCartney, John ^{[13
]}

McCauley, Dilara ^{[13
]}

Carlson, Robert ^{[13
]}

Norori, Sasha ^{[14
]}

Savona, Michael R. ^{[13
]}

Rashal, Tami ^{[13
]}

Mirza, Mansoor R. ^{[13
]}

Kauffman, Michael ^{[13
]}

Shacham, Sharon ^{[13
]}

机构：

[1] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada

[2] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA

[3] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA

[4] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA

[5] Alberta Hlth Serv, Calgary, AB, Canada

[6] Dana Farber Canc Inst, Boston, MA 02115 USA

[7] Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark

[8] Rigshosp, DK-2100 Copenhagen, Denmark

[9] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA

[10] Sarah Cannon Res Inst, Nashville, TN USA

[11] Gabrail Canc Ctr, Canton, OH USA

[12] Princess Margaret Canc Ctr, Toronto, ON, Canada

[13] Karyopharm Therapeut Inc, Newton, MA USA

[14] Ozmosis Res Inc, Toronto, ON, Canada

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[31] Safety and antitumor activity of selinexor (KPT-330), a first-in -class, oral XPO1 selective inhibitor of nuclear export: A phase I study expanded with colon cancer cohort.
Mau-Soerensen, Morten
Razak, Albiruni R. A.
Mahipal, Amit
Mahaseth, Hemchandra
Gerecitano, John F.
Shacham, Sharon
Yau, Cindy Y. F.
Lassen, Ulrik
Shields, Anthony Frank
McCauley, Dilara
Cooksey, Jennifer
Tan, David Shao Peng
Rashal, Tami
Shacham, Eran
Landesman, Yosef
Pond, Gregory
Oza, Amit M.
Kauffman, Michael
Siu, Lillian
Mirza, Mansoor Raza
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
[32] A first-in-class, first-in-human phase I trial of KPT-330 (selinexor), a selective inhibitor of unclear export (SINE) in patients (pis) with advanced solid tumors
Mau-Soerensen, Morten
Razak, Albiruni R. A.
Shields, Anthony Frank
Gabrall, Nashat Y.
Gereeltano, John F.
Shacham, Sharon
Lassen, Ulrlk Niels
Rashal, Taml
Cooksoy, Jennifer
Landosman, Yosof
Pond, Gregory
Oza, Amit M.
Kauffman, Michael
Siu, Lillian L.
Bedard, Philippe L.
Mahaseth, Hemchandra
Mlrza, Mansoor Raza
Mahipal, Arnit
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[33] Phase II study of the oral selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in dogs with lymphoma
Abbey R. Sadowski
Heather L. Gardner
Antonella Borgatti
Heather Wilson
David M. Vail
Joshua Lachowicz
Christina Manley
Avenelle Turner
Mary K. Klein
Angharad Waite
Alexandra Sahora
Cheryl A. London
BMC Veterinary Research, 14
[34] Phase II study of the oral selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in dogs with lymphoma
Sadowski, Abbey R.
Gardner, Heather L.
Borgatti, Antonella
Wilson, Heather
Vail, David M.
Lachowicz, Joshua
Manley, Christina
Turner, Avenelle
Klein, Mary K.
Waite, Angharad
Sahora, Alexandra
London, Cheryl A.
BMC VETERINARY RESEARCH, 2018, 14
[35] Selinexor (KTP-330)-a selective inhibitor of nuclear export (SINE): anti-tumor activity in diffuse large B-cell lymphoma (DLBCL)
Ben-Barouch, Sharon
Kuruvilla, John
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (01) : 15 - 21
[36] Effect of selinexor (KPT-330), a novel oral selective inhibitor of nuclear export (SINE), on tumor suppressors and cell cycle proteins in prostate cancer cells and regression of castration-resistant patient-derived xenograft tumor growth.
Maity, Sankar N.
Wu, Guanglin
Lu, Jing-Fang
Anh Hoang
Landesman, Yosef
McCauley, Dilara
Carlson, Robert
Rashal, Tami
Shacham, Sharon
Broom, Bradley McIntosh
Baggerly, Keith A.
Aparicio, Ana
Efstathiou, Eleni
Araujo, John C.
Logothetis, Christopher
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
[37] Results of a Phase I Dose Escalation Study of the Novel, Oral CRM1 Selective Inhibitor of Nuclear Export (SINE) KPT-335 in Dogs with Spontaneous Non-Hodgkin's Lymphomas (NHL)
Shacham, Sharon
Barnard, Sandra
Kisseberth, William
Ito, Daisuke
Jensen, Kiersten
Borgotti, Antonella
Henson, Michael
Wilson, Heather
McCauley, Dilara
Modiano, Jaime
Kauffman, Michael
London, Cheryl
BLOOD, 2012, 120 (21)
[38] Combination of Selective Inhibitor of Nuclear Export (SINE) Compounds, Selinexor and KPT-8602, with Venetoclax (ABT-199) Displays Enhanced Activity in Leukemia and Large Cell Lymphoma
Fischer, Melissa A.
Friedlander, Sharon
Hogdal, Leah
Arrate, Pia
Chang, Hua
Kashyap, Trinayan
Argueta, Christian
Klebanov, Boris
Senapedis, William
Baloglu, Erkan
Lee, Margaret S.
Shacham, Sharon
Savona, Michael R.
BLOOD, 2016, 128 (22)
[39] The effects of KPT-330, a selective inhibitor of nuclear export, on nuclear topoisomerase II alpha levels and etoposide activity in human myeloid leukemia HL-60 cells
Godley, Erica
Kanagasabai, Ragu
Karmahapatra, Soumendrakrishna
Yalowich, Jack C.
CANCER RESEARCH, 2016, 76
[40] First-in-class, first-in-human phase I trial of KPT-330, a selective inhibitor of nuclear export (SINE) in patients (pts) with advanced solid tumors.
Razak, Albiruni R. A.
Soerensen, Morten Mau
Mahipal, Amit
Shacham, Sharon
Yau, Cindy Y. F.
Lassen, Ulrik Niels
McCauley, Dilara
Cooksey, Jennifer
Tan, David Shao Peng
Saint-Martin, Jean-Richard
Landesman, Yossi
Pond, Gregory
Oza, Amit M.
Kauffman, Michael
Siu, Lillian L.
Mirza, Mansoor Raza
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)

← 1 2 3 4 5 →